NP35923 Cardiovascular & Respiratory Medicines
Details
- Supplier(s)
46 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Aguettant Ltd
- AOP Orphan Ltd
- Aspire Pharma Ltd
- Baxter Healthcare Ltd
- Beaumont Pharma Ltd
- Bowmed Ibisqus Ltd
- Chiesi Ltd
- Colonis Pharma Limited
- Consilient Health Ltd
- Correvio GmbH
- Crescent Pharma Limited
- CST Pharma Limited
- Day Lewis Medical Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Ennogen HealthCare
- Esteve Pharmaceuticals Ltd
- Focus Pharmaceuticals Ltd
- Galen Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Hameln Pharma Ltd
- Kent Pharma Ltd
- LEO Pharma
- Lupin Healthcare (UK) Ltd
- Martindale Pharma
- Mercury Pharma Group
- Morningside Pharmaceuticals Ltd
- Neon Healthcare Ltd
- P M Pharma
- Pfizer Liimted
- Ranbaxy (UK) Ltd
- Rosemont Pharmaceuticals Ltd
- ROVI BIOTECH LIMITED
- RPH Pharma Ltd
- Sandoz
- Selective Supplies Ltd
- Synchrony Pharma Ltd
- TECHDOW PHARMA ENGLAND LIMITED
- Tetris Pharma
- Teva UK Ltd
- Thornton and Ross
- Viatris UK Healthcare Ltd
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- GBP 53,346,651
- Topic
- Pharmaceutical products
- Published
- 25 July 2023
- Source
- uk:find_a_tender
Tender description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. Lot 2: Epoprostenol powder and solvent (pH12) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded a multi-supplier unranked framework agreement for the Lot to a maximum of 6 Framework Participants. Lot 3: Epinepherine (Adrenaline) Pre-filled syringes Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 5: Enoxaparin Sodium Injection Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 7: Isosorbide Mononitrate Modified Release Capsules and Tablets Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 8: Diltiazem Hydrochloride Modified Release Capsules and Tablets Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 9: Verapamil Hydrochloride Modified Release Capsules and Tablets Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 10: Nifedipine Modified Release Capsules and Tablets Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 11: Theophylline Modified Release Capsules and Tablets Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 12: Branded and Branded Generic Inhalers Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 13: Iloprost Medicines Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 14: Dalteparin Injection Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 15: Tinzaparin Sodium Injection Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 17: Tresprostinil Injection Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Lot 18: All other Cardiovascular & Respiratory Medicines Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was treated as an individual Lot. The Authority has awarded each product line to a single Framework Participant. Lot 16: Icatibant Solution for Injection Supply of Icatibant Solution for Injection to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement on a line by line basis to a maximum of 6 Framework Participants.
Timeline
- Completed: Award date3 April 2023
- Completed: Award published25 July 2023Current notice
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
6 similar open tenders
See more open tenders related to NP35923 Cardiovascular & Respiratory Medicines.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS National Services Scotland.
- 19£4.6m
- 9£1.1m
- 6£445.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 742£1.9bn
- 231£2.0bn
- 136£1.4bn
- 122£59.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
